Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07290673 · ClinicalTrials.gov registry record · NA
Evaluating the Efficacy of FoundationDRS Solo in Addition to Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers
A NA study, sponsored by Samaritan Biologics.
- Not yet
- Registry status
- NA
- Development phase
- 124
- Enrollment target
NCT07290673 is a NA study that has not yet begun recruiting, run by Samaritan Biologics. The registered enrollment target is 124 participants.
The verdict
NCT07290673, a NA study, has not yet begun recruiting, sponsored by Samaritan Biologics.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 124 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if using FoundationDRS Solo improves healing of chronic, non-healing foot ulcers in diabetic patients. The main question that this study aims to answer is: Does FoundationDRS Solo, when used in conjunction with standard of care wound management techniques, result in a higher percentage of target ulcers achieving complete closure (i.e. healing) as compared to ulcers being treated with standard of care alone after 12 weeks of treatment. One ulcer on each participant's foot will receive weekly applications of 1) FoundationDRS Solo and standard of care wound management or 2) standard of care wound management alone. Pictures of the ulcer and measurements of its size will be measured every week to track its healing progress over a total treatment period of 12 weeks. Additionally, the participants will be asked to fill out a questionnaire about the wound impacts their life and their quality of life.
Interventions
- OTHER Standard of Care
- OTHER FoundationDRS Solo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2026-04-01 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07290673
The ClinicalTrials.gov registry entry for NCT07290673 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Samaritan Biologics, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT07290673 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07290673 about?
NCT07290673 is a clinical study titled "Evaluating the Efficacy of FoundationDRS Solo in Addition to Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers". The goal of this clinical trial is to learn if using FoundationDRS Solo improves healing of chronic, non-healing foot ulcers in diabetic patients. The main question that this study aims to answer is: Does FoundationDRS Solo, when used in conjunction with standard of care wound management technique...
What is the current status of trial NCT07290673?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 124 participants. The study started on 2026-04-01. Estimated completion is 2027-12-31.
What interventions are being tested in trial NCT07290673?
The interventions under investigation include: Standard of Care (OTHER), FoundationDRS Solo (OTHER).
Who is sponsoring clinical trial NCT07290673?
This trial is sponsored by Samaritan Biologics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.